首页|体外二氧化碳清除联合连续性肾脏替代治疗对急性呼吸窘迫综合征患者膈肌功能的影响

体外二氧化碳清除联合连续性肾脏替代治疗对急性呼吸窘迫综合征患者膈肌功能的影响

扫码查看
目的 探讨体外二氧化碳清除(ECCO2R)联合连续性肾脏替代治疗(CRRT)对接受机械通气的急性呼吸窘迫综合征(ARDS)患者呼吸效率和膈肌功能的影响。方法 采用前瞻性随机对照研究方法,纳入2019 年 1 月至 2021 年 1 月河南省人民医院呼吸与危重症医学科收治的 60 例轻中度ARDS患者,并按随机数字表法分为观察组和对照组,每组 30 例。所有患者均给予抗感染、抗炎、机械通气等治疗,在此基础上,观察组给予ECCO2R联合CRRT治疗,对照组给予床旁CRRT治疗。记录患者性别、年龄、病因、急性生理学与慢性健康状况评分Ⅱ(APACHEⅡ)等一般资料;分别于治疗 12h和 24h进行血气分析[动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、氧合指数(PaO2/FiO2)],记录呼吸力学参数[包括潮气量、呼吸频率、最大呼气压(MEP)和最大吸气压(MIP)]并计算浅快呼吸指数(RSBI),用酶联免疫吸附试验(ELISA)检测血清中谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)和超氧化物歧化酶(SOD)水平;治疗 24h超声测量膈肌活动度及膈肌厚度。结果 两组患者年龄、性别、病因、APACHEⅡ评分比较差异均无统计学意义,说明两组基线资料均衡可比。与本组 12h比较,观察组治疗 24 h PaO2、PaO2/FiO2 明显升高,PaCO2 明显下降,RSBI明显下降,MEP、MIP明显升高,血清GSH-Px、MDA明显下降,SOD明显升高;对照组仅PaCO2 明显下降。观察组治疗 12h和24h时PaCO2 较对照组明显下降[mmHg(1 mmHg≈0。133 kPa):55。05±7。57 比 59。49±6。95,52。77±7。88 比58。25±6。92,均P<0。05],但PaO2、PaO2/FiO2 与对照组比较差异均无统计学意义。与对照组比较,观察组治疗12h和24 h RSBI显著下降(次·min-1·L-1:85。92±8。83比90。38±3。78,75。73±3。86比90。05±3。66,均P<0。05),MEP、MIP明显升高[MEP(mmH2O,1 mmH2O≈0。01 kPa):86。64±5。99 比 83。88±4。18,93。70±5。59 比 85。04±3。73;MIP(mmH2O):44。19±6。66 比 41。17±3。13,57。52±5。28 比 42。34±5。39,均P<0。05],血清GSH-Px和MDA显著下降[GSH-Px(mg/L):78。52±8。72 比 82。10±3。37,57。11±4。67 比 81。17±5。13;MDA(μmol/L):7。84±1。97 比 8。71±0。83,3。67±0。78 比 8。41±1。09,均P<0。05],SOD显著升高(U/L:681。85±49。24 比 659。40±26。47,782。32±40。56 比 676。65±51。97,均P<0。05)。与对照组相比,观察组治疗 24h膈肌厚度和膈肌活动度均明显增加[膈肌厚度(cm):1。93±0。28 比 1。40±0。24,膈肌增厚分数:(0。22±0。04)%比(0。19±0。02)%,平静呼吸膈肌位移(cm):1。42±0。13 比 1。36±0。06,深吸气后膈肌位移(cm):5。11±0。75 比 2。64±0。59,P<0。05]。结论 ECCO2R联合CRRT可降低ARDS无创通气患者的呼吸作功及氧化应激水平,保护膈肌功能。
Impact of extracorporeal carbon dioxide removal combined with continuous renal replacement therapy on diaphragmatic function in patients with acute respiratory distress syndrome
Objective To investigate the effects of extracorporeal carbon dioxide removal(ECCO2R)combined with continuous renal replacement therapy(CRRT)on respiratory efficiency and diaphragm function in patients with acute respiratory distress syndrome(ARDS)received mechanical ventilation.Methods A prospective randomized controlled study was conducted.Sixty patients with mild to moderate ARDS admitted to the department of respiratory and critical care medicine of Henan Provincial People's Hospital from January 2019 to January 2021 were enrolled,and they were divided into observation group and control group according to the random number table method,with 30 cases in each group.All patients received antibiotics,anti-inflammatory,and mechanical ventilation therapy.On this basis,the observation group received ECCO2R and CRRT,while the control group received bedside CRRT.Baseline data including gender,age,etiology,acute physiology and chronic health evaluationⅡ(APACHEⅡ),etc.,were recorded.Arterial blood gas analysis[including arterial partial pressure of oxygen(PaO2),arterial partial pressure of carbon dioxide(PaCO2),and oxygenation index(PaO2/FiO2)]was performed at 12 hours and 24 hours during the treatment,and respiratory mechanics parameters[including tidal volume,respiratory rate,maximum expiratory pressure(MEP),and maximum inspiratory pressure(MIP)]were recorded,and rapid shallow breathing index(RSBI)was calculated.The levels of glutathione peroxidase(GSH-Px),malondialdehyde(MDA),and superoxide dismutase(SOD)in serum were detected by enzyme-linked immunosorbent assay(ELISA).Diaphragm thickness and diaphragm activity were measured by ultrasonography at 24 hours during the treatment.Results There were no significantly differences in age,gender,etiology,and APACHEⅡscore between the two groups,indicating that the baseline data of the two groups were balanced and comparable.Compared with the 12 hours after treatment,the PaO2 and PaO2/FiO2 in the observation group significantly increased,PaCO2 significantly decreased,RSBI significantly decreased,MEP and MIP significantly increased,and serum GSH-Px and MDA significantly decreased,while SOD significantly increased at 24 hours during the treatment.In the control group,only PaCO2 significantly decreased.Compared with the control group,the PaCO2 significantly decreased in the observation group at 12 hours and 24 hours[mmHg(1 mmHg≈0.133 kPa):55.05±7.57 vs.59.49±6.95,52.77±7.88 vs.58.25±6.92,both P<0.05],but no significantly differences in PaO2 and PaO2/FiO2.Compared with the control group,the observation group showed significant decreases in RSBI at 12 hours and 24 hours(times·min-1·L-1:85.92±8.83 vs.90.38±3.78,75.73±3.86 vs.90.05±3.66,both P<0.05),significant increases in MEP and MIP[MEP(mmH2O,1 mmH2O≈0.01 kPa):86.64±5.99 vs.83.88±4.18,93.70±5.59 vs.85.04±3.73;MIP(mmH2O):44.19±6.66 vs.41.17±3.13,57.52±5.28 vs.42.34±5.39,all P<0.05],and significant decreases in serum GSH-Px and MDA[GSH-Px(mg/L):78.52±8.72 vs.82.10±3.37,57.11±4.67 vs.81.17±5.13;MDA(μmol/L):7.84±1.97 vs.8.71±0.83,3.67±0.78 vs.8.41±1.09,all P<0.05],as well as a significant increase in SOD(U/L:681.85±49.24 vs.659.40±26.47,782.32±40.56 vs.676.65±51.97,both P<0.05).Compared with the control group,the observation group showed significant increases in diaphragm thickness and diaphragm activity at 24 hours of treatment[diaphragm thickness(cm):1.93±0.28 vs.1.40±0.24,diaphragmatic thickening fraction:(0.22±0.04)%vs.(0.19±0.02)%,quiet breathing diaphragm displacement(cm):1.42±0.13 vs.1.36±0.06,deep breathing diaphragm displacement(cm):5.11±0.75 vs.2.64±0.59,all P<0.05].Conclusion ECCO2R combined with CRRT can reduce work of breathing and oxidative stress levels in ARDS patients receiving non-invasive ventilation,and protect diaphragm function.

Extracorporeal carbon dioxide removalAcute respiratory distress syndromeDiaphragmMechanical ventilation

忽新刚、张文稳、蒋亚芬、张杰、刘智达、田翠杰、王学林、程剑剑

展开 >

河南省人民医院,郑州大学人民医院呼吸与危重症医学科,郑州 450003

河南省人民医院,郑州大学人民医院公共事业发展部,郑州 450003

体外二氧化碳清除 急性呼吸窘迫综合征 膈肌 机械通气

河南省科技发展计划项目

212400410060

2024

中华危重病急救医学
中华医学会

中华危重病急救医学

CSTPCD北大核心
影响因子:3.049
ISSN:2095-4352
年,卷(期):2024.36(2)
  • 19